Search
Analysis of Urinary Midkine and Volatile Organic Compound (VOC) Levels Using a Breath Analyzer for Screening and Early Diagnosis of Lung Cancer
223-231
Abstract : 27
PDF : 29
Neutrophil-Lymphocyte Ratio (NLR) as a Prognostic Marker in Advanced Lung Cancer Patients Undergoing First-Line Treatment
209-213
Abstract : 575
PDF : 247
Profil Pasien Kanker Paru Primer yang Dirawat Inap dan Rawat Jalan di Rumah Sakit Umum Daerah Dr Soetomo Surabaya [Profile of Primary Lung Cancer Patients in Dr. Soetomo General Hospital Surabaya]
65-71
Abstract : 2176
PDF : 4108
The Influence of Nigella sativa on the Increase of IFN-γ and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy
31-38
Abstract : 529
PDF : 229
Volatile Organic Compounds (VOC) and Serum Leukotriene B4 between COPD Patients and COPD with Lung Cancer Patients
222-227
Abstract : 375
PDF : 260
The Effect of Anemia on Prognostic in Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
120-129
Abstract : 526
PDF : 315
Giant Cell Lung Carcinoma: A Case Report of a Rare Histology Type of Non-Small Cell Lung Cancer
143-148
Abstract : 613
PDF : 384
Fungal Profile in Patients with Lung Cancer Receiving First-Line Chemotherapy
250-255
Abstract : 36
PDF : 33
Assessment of Quality of Life in Advanced-Stage Lung Cancer Patients Using EORTC QLQ-C30 Questionnaire
228-235
Abstract : 545
PDF : 304
Risk Factors and Challenging Management of Lung Adenocarcinoma in Young Adult Women: Case Series
94-98
Abstract : 1075
PDF : 516
Efek Samping Hematologi Akibat Kemoterapi dan Tatalaksananya [Hemathologic Adverse Effect Related to Chemotherapy]
22-28
Abstract : 4029
PDF : 51372
Monitoring and Evaluation of Therapy Response in Advanced-Stage Lung Cancer Treated with Systemic Therapy
183-190
Abstract : 169
PDF : 225
Hematologic Paraneoplastic Syndrome in Newly Diagnosed Patients with Lung Cancer
18-29
Abstract : 908
PDF : 730
The Effects of Inspiratory Muscle Training in Lung Cancer Patients: A Scoping Review
75-82
Abstract : 326
PDF : 302
Anaplastic Lymphoma Kinase (ALK) Rearrangement of Lung Adenocarcinoma among North Sumatera Population
47-53
Abstract : 212
PDF : 208
The Time to Progression in Lung Adenocarcinoma Patients Receiving First- and Second-Generation EGFR-TKI in Indonesia
22-30
Abstract : 588
PDF : 362
Implementing Palliative and End-of-Life Care in Lung Cancer: When to Start?
64-71
Abstract : 796
PDF : 643
Nutrisi pada Penderita Kanker Paru [Nutrition Management in Lung Cancer Patients]
91-100
Abstract : 2406
PDF : 15364




































JR (